| 2026-05-21 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -12,02k | 262,41k | Vendita | 21,84 | 43,44k | -21,67% |
| 2026-05-05 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | 4,11k | 0,00 | Derivative Exercise and Retained Stock | - | 35,58k | 13,05% |
| 2026-05-05 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -1,67k | 43,23k | Derivative Exercise and Sale | 25,92 | 35,58k | - |
| 2026-05-05 | Mr. Erich A. FritzExec. VP of Global Supply Chain | -469,00 | 12,15k | Derivative Exercise and Sale | 25,92 | 903,00 | - |
| 2026-05-05 | Mr. Erich A. FritzExec. VP of Global Supply Chain | 903,00 | 0,00 | Derivative Exercise and Retained Stock | - | 903,00 | - |
| 2026-05-05 | Mr. Kevin Fuller GregoryGlobal CMO | -573,00 | 14,85k | Derivative Exercise and Sale | 25,92 | 6,42k | - |
| 2026-05-05 | Mr. Kevin Fuller GregoryGlobal CMO | 1,10k | 0,00 | Derivative Exercise and Retained Stock | - | 6,42k | 20,77% |
| 2026-05-05 | Mr. Kevin R. HerbertExec. VP & President of North America | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 23,29k | 5,12% |
| 2026-05-05 | Mr. Kevin R. HerbertExec. VP & President of North America | -366,00 | 9,48k | Derivative Exercise and Sale | 25,92 | 23,29k | - |
| 2026-05-05 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | 3,64k | 0,00 | Derivative Exercise and Retained Stock | - | 86,34k | 4,40% |
| 2026-05-05 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | -2,85k | 73,75k | Derivative Exercise and Sale | 25,92 | 86,34k | - |
| 2026-05-05 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | 2,25k | 0,00 | Derivative Exercise and Retained Stock | - | 42,29k | 5,61% |
| 2026-05-05 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -912,00 | 23,63k | Derivative Exercise and Sale | 25,92 | 42,29k | - |
| 2026-05-05 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | 5,18k | 0,00 | Derivative Exercise and Retained Stock | - | 30,40k | 20,56% |
| 2026-05-05 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -2,10k | 54,53k | Derivative Exercise and Sale | 25,92 | 30,40k | - |
| 2026-05-05 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -1,96k | 50,87k | Derivative Exercise and Sale | 25,92 | 68,61k | - |
| 2026-05-05 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | 4,84k | 0,00 | Derivative Exercise and Retained Stock | - | 68,61k | 7,58% |
| 2026-05-05 | Mr. Kenneth G. RomanziCEO & Director | 7,37k | 0,00 | Derivative Exercise and Retained Stock | - | 7,37k | - |
| 2026-05-05 | Mr. Kenneth G. RomanziCEO & Director | -5,75k | 149,09k | Derivative Exercise and Sale | 25,92 | 7,37k | - |
| 2026-04-20 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -1,29k | 34,89k | Sale to Issuer | 27,07 | 31,47k | -3,93% |
| 2026-04-20 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | -3,51k | 95,07k | Sale to Issuer | 27,07 | 82,70k | -4,07% |
| 2026-04-20 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -951,00 | 25,74k | Sale to Issuer | 27,07 | 40,04k | -2,32% |
| 2026-04-20 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -1,57k | 42,42k | Sale to Issuer | 27,07 | 25,22k | -5,85% |
| 2026-04-20 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -1,57k | 42,42k | Sale to Issuer | 27,07 | 63,78k | -2,40% |
| 2026-03-06 | Mr. Kevin Fuller GregoryGlobal CMO | -7,97k | 0,00 | Other Disposition | - | 5,32k | -59,98% |
| 2026-03-06 | Mr. Erich A. FritzExec. VP of Global Supply Chain | -8,18k | 0,00 | Other Disposition | - | 10,76k | -43,19% |
| 2026-03-06 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -7,76k | 0,00 | Other Disposition | - | 77,39k | -9,11% |
| 2026-03-06 | Mr. Kenneth G. RomanziCEO & Director | -29,93k | 0,00 | Other Disposition | - | 102,88k | -22,53% |
| 2026-03-06 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -5,42k | 0,00 | Other Disposition | - | 40,99k | -11,67% |
| 2026-03-06 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -10,09k | 0,00 | Other Disposition | - | 42,00k | -19,37% |
| 2026-03-06 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | -11,80k | 0,00 | Other Disposition | - | 71,56k | -14,15% |
| 2026-03-06 | Mr. Kevin R. HerbertExec. VP & President of North America | -7,12k | 0,00 | Other Disposition | - | 17,01k | -29,52% |
| 2026-03-06 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -7,25k | 0,00 | Other Disposition | - | 21,41k | -25,30% |
| 2026-03-13 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -19,52k | 475,21k | Vendita | 24,35 | 67,67k | -22,38% |
| 2026-03-13 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -15,38k | 377,19k | Vendita | 24,52 | 31,44k | -32,85% |
| 2026-03-13 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -3,61k | 88,41k | Other Disposition | 24,49 | 31,44k | -10,30% |
| 2026-03-13 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -4,00k | 98,80k | Vendita | 24,70 | 46,41k | -7,94% |
| 2026-03-10 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -3,09k | 77,14k | Sale to Issuer | 24,76 - 25,08 | 50,44k | -5,77% |
| 2026-03-10 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | -5,19k | 129,37k | Sale to Issuer | 24,76 - 25,08 | 78,20k | -6,22% |
| 2026-03-10 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -1,84k | 45,98k | Sale to Issuer | 24,76 - 25,08 | 50,41k | -3,53% |
| 2026-03-10 | Mr. Kevin R. HerbertExec. VP & President of North America | -2,08k | 51,87k | Sale to Issuer | 24,76 - 25,08 | 22,15k | -8,58% |
| 2026-03-10 | Mr. Kevin Fuller GregoryGlobal CMO | -1,50k | 37,54k | Sale to Issuer | 25,08 | 5,32k | -21,98% |
| 2026-03-10 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -2,56k | 63,90k | Sale to Issuer | 24,76 - 25,08 | 87,19k | -2,85% |
| 2026-03-10 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -2,32k | 57,78k | Sale to Issuer | 24,76 - 25,08 | 28,29k | -7,57% |
| 2026-03-06 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | 715,00 | 0,00 | Derivative Exercise and Retained Stock | - | 23,72k | 3,11% |
| 2026-03-06 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -371,00 | 9,30k | Derivative Exercise and Sale | 25,06 | 23,72k | - |
| 2026-03-06 | Mr. Kevin R. HerbertExec. VP & President of North America | 871,00 | 0,00 | Derivative Exercise and Retained Stock | - | 17,01k | 5,40% |
| 2026-03-06 | Mr. Kevin R. HerbertExec. VP & President of North America | -368,00 | 9,22k | Derivative Exercise and Sale | 25,06 | 17,01k | - |
| 2026-03-06 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | -878,00 | 22,00k | Derivative Exercise and Sale | 25,06 | 71,56k | - |
| 2026-03-06 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | 1,12k | 0,00 | Derivative Exercise and Retained Stock | - | 71,56k | 1,60% |
| 2026-03-06 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | 601,00 | 0,00 | Derivative Exercise and Retained Stock | - | 52,25k | 1,16% |
| 2026-03-06 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -312,00 | 7,82k | Derivative Exercise and Sale | 25,06 | 52,25k | - |
| 2026-03-06 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | 1,01k | 0,00 | Derivative Exercise and Retained Stock | - | 33,78k | 3,09% |
| 2026-03-06 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -527,00 | 13,21k | Derivative Exercise and Sale | 25,06 | 33,78k | - |
| 2026-03-06 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | 867,00 | 0,00 | Derivative Exercise and Retained Stock | - | 74,21k | 1,18% |
| 2026-03-06 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -450,00 | 11,28k | Derivative Exercise and Sale | 25,06 | 74,21k | - |
| 2025-12-12 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -1,70k | 37,89k | Vendita | 22,29 | 73,34k | -2,27% |
| 2025-11-24 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -1,50k | 30,84k | Other Disposition | 20,56 | 23,01k | -6,12% |
| 2025-11-12 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -8,88k | 181,77k | Vendita | 20,46 | 32,77k | -21,33% |
| 2025-11-17 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -3,57k | 74,24k | Other Disposition | 20,79 | 32,77k | -9,83% |
| 2025-11-18 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -5,00k | 102,25k | Vendita | 20,45 | 46,23k | -9,76% |
| 2025-11-14 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -3,80k | 79,08k | Vendita | 20,81 | 24,51k | -13,42% |
| 2025-11-04 | Mr. Martin GonzalezInsider | 4,12k | 0,00 | Derivative Exercise and Retained Stock | - | 42,52k | 10,73% |
| 2025-11-04 | Mr. Martin GonzalezInsider | -1,67k | 23,00k | Derivative Exercise and Sale | 13,75 | 42,52k | - |
| 2025-11-04 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | 2,26k | 0,00 | Derivative Exercise and Retained Stock | - | 28,31k | 8,67% |
| 2025-11-04 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -985,00 | 13,54k | Derivative Exercise and Sale | 13,75 | 28,31k | - |
| 2025-11-04 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | -1,76k | 24,15k | Derivative Exercise and Sale | 13,75 | 47,83k | - |
| 2025-11-04 | Mr. L. Shane JonesExec. VP of Finance, CFO & Treasurer | 2,25k | 0,00 | Derivative Exercise and Retained Stock | - | 47,83k | 4,93% |
| 2025-11-04 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | 1,18k | 0,00 | Derivative Exercise and Retained Stock | - | 51,23k | 2,36% |
| 2025-11-04 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -614,00 | 8,44k | Derivative Exercise and Sale | 13,75 | 51,23k | - |
| 2025-11-04 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 45,22k | 6,61% |
| 2025-11-04 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -1,14k | 15,65k | Derivative Exercise and Sale | 13,75 | 45,22k | - |
| 2025-11-04 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | 2,81k | 0,00 | Derivative Exercise and Retained Stock | - | 75,04k | 3,88% |
| 2025-11-04 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -1,13k | 15,59k | Derivative Exercise and Sale | 13,75 | 75,04k | - |
| 2025-09-26 | Mr. Kevin Fuller GregoryGlobal CMO | -1,26k | 20,04k | Sale to Issuer | 15,89 | 2,43k | -34,17% |
| 2025-08-26 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -9,67k | 161,92k | Vendita | 16,71 - 16,77 | 72,24k | -11,81% |
| 2025-08-13 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -5,00k | 82,55k | Vendita | 16,51 | 50,05k | -9,08% |
| 2025-08-13 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -10,00k | 165,33k | Vendita | 16,54 | 26,05k | -27,73% |
| 2025-07-21 | Mr. Jonathan D. LanoySenior VP, CAO & Principal Accounting Officer | -341,00 | 5,05k | Sale to Issuer | 14,80 | 55,05k | -0,62% |
| 2025-07-21 | Ms. Tracee ComstockInsider | -1,24k | 18,28k | Sale to Issuer | 14,80 | 64,45k | -1,88% |
| 2025-07-21 | Mr. Nathan G. BrowerExec. VP, General Counsel & Secretary | -1,49k | 22,07k | Sale to Issuer | 14,80 | 36,05k | -3,97% |
| 2025-07-21 | Mr. Daniel C. NormanExec. VP & President of Asia/Pacific (APAC) | -1,70k | 25,20k | Sale to Issuer | 14,80 | 42,42k | -3,86% |
| 2025-07-21 | Mr. Terrence O. MooreheadInsider | -9,30k | 137,67k | Sale to Issuer | 14,80 | 444,03k | -2,05% |
| 2025-07-21 | Mr. Martin GonzalezInsider | -3,78k | 55,96k | Sale to Issuer | 14,80 | 38,40k | -8,96% |
| 2025-07-21 | Mr. Bryant J. YatesExec. VP and President of Europe & Latin America | -1,74k | 25,72k | Sale to Issuer | 14,80 | 81,91k | -2,08% |
| 2025-06-27 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Società | -2,85M | 32,71M | Vendita | 11,46 | 64,17k | -97,80% |
| 2025-06-05 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Società | -2,85M | 0,00 | Vendita | - | 2,85M | -50,00% |
| 2025-06-05 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Società | 2,85M | 0,00 | Acquisto | - | 2,85M | - |